Co-Diagnostics, Inc. (CODX) Research

Co-Diagnostics, Inc. (CODX) is a molecular diagnostics company that designs, produces, and globally markets specialized reagents. These components are integral to diagnostic tests that identify and analyze nucleic acid molecules. The company's product portfolio features the Co-Dx PCR platform, enabling Polymerase Chain Reaction (PCR) testing for patients in both clinical (point-of-care) and home settings. They offer an extensive range of PCR diagnostic tests for numerous conditions, including COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. Beyond human health, Co-Diagnostics develops three distinct multiplexed tests for screening mosquitos to detect disease-carrying pathogens. Their advanced molecular tools also serve broader applications, encompassing infectious disease detection, liquid biopsy for cancer screening, and agricultural uses such as identifying genetic traits in plant and animal genomes. Complementing these offerings is a portable diagnostic device, specifically engineered to make PCR testing accessible directly to patients in various settings. The company was founded in 2013 and is based in Salt Lake City, Utah.

Market snapshot

Symbol
CODX
Price
$3.37
Day change
+1.20%
Market cap
$3.8M
P/E ratio
-0.16x
52-week range
1.26-46.5
Sector
Healthcare
Industry
Medical - Devices
Next earnings
in 2 months
Analyst price target
$180

Recent news

  • EXCLUSIVE: Co-Diagnostics Ships Diagnostic Tests To India Ahead Of TB Study Launch

    These materials are necessary to begin clinical performance studies of the TB test on the PCR platform, as the company completes final steps toward initiating those studies in the near term.

  • EXCLUSIVE: Co-Diagnostics Expands South Asia Reach, Targets $13 Billion Market Opportunity

    CoSara is the Indian joint venture between Co-Dx and Ambalal Sarabhai Enterprises Limited.

Peer companies

  • Adagio Medical Holdings, Inc. (ADGM)
  • Aethlon Medical, Inc. (AEMD)
  • Allurion Technologies Inc. (ALUR)
  • Dogwood Therapeutics, Inc. (DWTX)
  • enVVeno Medical Corporation (NVNO)
  • ProPhase Labs, Inc. (PRPH)
  • Sintx Technologies, Inc. (SINT)
  • Tenon Medical, Inc. (TNON)

Recent insider activity

  • Egan Dwight H — A-Award (4584 shares) on 2026-05-23
  • Egan Dwight H — D-Return (1633 shares) on 2026-05-23
  • Egan Dwight H — M-Exempt (4584 shares) on 2026-05-23
  • Brown Brian Lee — A-Award (3750 shares) on 2026-05-23
  • Brown Brian Lee — D-Return (1350 shares) on 2026-05-23

Open Co-Diagnostics, Inc. (CODX) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.